Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing ’s Sarcoma

Three-year Follow up of GMCSF/bi-shRNAfurin DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing’s Sarcoma Molecular Therapy 24, 1478 (August 2016). doi:10.1038/mt.2016.86 Authors: Maurizio Ghisoli, Minal Barve, Robert Mennel, Carl Lenarsky, Staci Horvath, Gladice Wallraven, Beena O Pappen, Sam Whiting, Donald Rao, Neil Senzer & John Nemunaitis
Source: Molecular Therapy - Category: Genetics & Stem Cells Authors: Source Type: research